atezolizumab + cobimetinib + vemurafenib
Metastatic
,
+1 more
state
atezolizumab + cobimetinib + vemurafenib
Metastatic
,
+1 more
state
binimetinib + encorafenib
Metastatic
,
+1 more
state
binimetinib + encorafenib
binimetinib + encorafenib
Metastatic
,
+1 more
state
cobimetinib + vemurafenib
Metastatic
,
+1 more
state
cobimetinib + vemurafenib
cobimetinib + vemurafenib
Metastatic
,
+1 more
state
Metastatic
,
+1 more
state
Metastatic
,
+1 more
state
Metastatic
,
+1 more
state